Rating History for Krystal Biotech (KRYS) by Goldman Sachs

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
9/24/2026 Andrea Newkirk New Coverage Buy
(N/A)
441.00
(N/A)
350.88
(311.50)
-11.22% Details